# Delivery Order #75F40126F80143

FDA Orders Synensys to Develop a Biocompatibility Assessment Framework

**Buyer:** Food and Drug Administration

**Award Amount:** $2,448,445.47
**Ceiling:** $7,201,929.62

**Period of Performance:** Sep 15, 2026 - Sep 14, 2027

**Identifier:** 75F40126F80143
**NAICS:** 541612

The FDA issued Synensys, LLC a delivery order under the OASIS+ Service-Disabled Veteran-Owned Small Business multiple-award contract. Synensys is a service-disabled veteran-owned small business that provides integrated services to federal agencies; no parent company is identified. The work applies systems-theoretic methods—including STAMP, CAST, and STPA—to develop a candidate rubric for evaluating biocompatibility and begin establishing a learning regulatory system. These tools are intended to support more structured assessment and regulatory learning relevant to medical-product safety. The scope is focused on developing the assessment framework and initiating the regulatory-learning effort. The order is initially planned as a one-year effort, with potential work extending over several years. The OASIS+ contract vehicle is a multi-agency acquisition program; the available record does not identify the order’s competition method or provide a sole-source justification. No subcontractors, related prior contracts, or original solicitation details are provided. The record places performance in Peachtree City, Georgia.

### Description

APPLICATION OF SYSTEMS-THEORETIC METHODS (STAMP / CAST / STPA) TO DEVELOP A CANDIDATE BIOCOMPATIBILITY ASSESSMENT RUBRIC AND INITIATE A LEARNING REGULATORY SYSTEM FOR BIOCOMPATIBILITY

[View original record](https://www.usaspending.gov/award/CONT_AWD_75F40126F80143_7524_47QRCA24DV311_4732)
